X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (689) 689
Publication (53) 53
Book Chapter (12) 12
Book Review (12) 12
Book / eBook (7) 7
Conference Proceeding (5) 5
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (347) 347
oncology (153) 153
index medicus (121) 121
male (104) 104
female (102) 102
middle aged (99) 99
hematology (98) 98
adult (85) 85
aged (81) 81
antineoplastic agents - therapeutic use (78) 78
antineoplastic combined chemotherapy protocols - therapeutic use (71) 71
rituximab (69) 69
chemotherapy (55) 55
treatment outcome (55) 55
non-hodgkins-lymphoma (54) 54
aged, 80 and over (45) 45
clinical trials as topic (44) 44
prognosis (41) 41
lymphoma, non-hodgkin - drug therapy (40) 40
leukemia, lymphocytic, chronic, b-cell - drug therapy (39) 39
chronic lymphocytic-leukemia (38) 38
lymphoma (37) 37
lymphomas (37) 37
disease-free survival (35) 35
antineoplastic agents - adverse effects (32) 32
follicular lymphoma (32) 32
antibodies, monoclonal - therapeutic use (31) 31
antineoplastic combined chemotherapy protocols - adverse effects (31) 31
cancer (31) 31
neoplasm staging (31) 31
phase-ii trial (29) 29
therapy (28) 28
b-cell lymphoma (26) 26
chronic lymphocytic leukemia (26) 26
survival (26) 26
survival analysis (26) 26
trial (26) 26
article (25) 25
positron-emission-tomography (25) 25
hematology, oncology and palliative medicine (23) 23
remission induction (23) 23
bendamustine hydrochloride (22) 22
care and treatment (22) 22
leukemia (22) 22
doxorubicin - administration & dosage (21) 21
research (21) 21
antineoplastic combined chemotherapy protocols - administration & dosage (20) 20
clinical trials (20) 20
hodgkin disease - drug therapy (20) 20
abridged index medicus (19) 19
antibodies, monoclonal, murine-derived (19) 19
fluorodeoxyglucose f18 (19) 19
young adult (19) 19
adolescent (18) 18
antineoplastic agents - administration & dosage (18) 18
cyclophosphamide (18) 18
disease (18) 18
drug therapy (18) 18
fdg-pet (18) 18
hemic and lymphatic diseases (18) 18
lymphoma - drug therapy (18) 18
recurrence (18) 18
united states (18) 18
animals (17) 17
follow-up (17) 17
hodgkin disease - pathology (17) 17
lymphoma, follicular - drug therapy (17) 17
multicenter (17) 17
neoplasms - drug therapy (17) 17
vincristine - administration & dosage (17) 17
bendamustine (16) 16
lymphoma - therapy (16) 16
medicine, general & internal (16) 16
plus rituximab (16) 16
follow-up studies (15) 15
lymphoma, non-hodgkin - pathology (15) 15
nitrogen mustard compounds - therapeutic use (15) 15
open-label (15) 15
prednisone - administration & dosage (15) 15
survival rate (15) 15
cyclophosphamide - administration & dosage (14) 14
lymphoma - pathology (14) 14
monoclonal antibodies (14) 14
radiopharmaceuticals (14) 14
response criteria (14) 14
toxicity (14) 14
anti-cd20 monoclonal-antibody (13) 13
bortezomib (13) 13
cll (13) 13
diagnosis (13) 13
hodgkin lymphoma (13) 13
inhibitor (13) 13
lymphoma, b-cell - drug therapy (13) 13
positron-emission tomography (13) 13
antineoplastic agents (12) 12
drug administration schedule (12) 12
etoposide - administration & dosage (12) 12
lymphoma - diagnostic imaging (12) 12
non-hodgkin lymphoma (12) 12
phase-ii (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Hematology/oncology clinics of North America, ISBN 9781416058755, Volume 22, no. 5., xiv, p. 781-1097
Book
2001, New frontiers in cancer therapy, ISBN 9781903557013, x, 287
Book
1993, Seminars in oncology, Volume 20, no. 5, suppl. 5., 155
Book
Basic and clinical oncology, ISSN 1073-0028, 1993
Journal
1990, Seminars in oncology, Volume 17, no. 5, suppl. 8., 78
Book
2001, 2nd ed. rev. and expanded., Basic and clinical oncology, ISBN 9780824705435, Volume 26., xiv, 623
Book
Blood, ISSN 0006-4971, 05/2018, Volume 131, Issue 22, pp. 2408 - 2409
Is that really true? What is clear is that better surrogate end points are needed for follicular lymphoma (FL) clinical trials so we can predict outcomes... 
TRIAL | RISK | CHOP | FOLLICULAR LYMPHOMA | HEMATOLOGY | RITUXIMAB | Lymphoma, Follicular | Humans | Prognosis
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 02/2006, Volume 354, Issue 5, pp. 496 - 507
  Other benign processes associated with cells that have increased glucose use, such as inflammatory cells or hyperplastic bone marrow or thymic cells, also... 
CELL LUNG-CANCER | FDG-PET | BREAST-CANCER | LIVER METASTASES | MEDICINE, GENERAL & INTERNAL | HEAD-AND-NECK | PREOPERATIVE CHEMOTHERAPY | COLORECTAL-CANCER | NON-HODGKINS-LYMPHOMA | COMPUTED-TOMOGRAPHY | F-18 FLUORODEOXYGLUCOSE | Tomography | Medical research | Medical imaging | Glucose | Tumors | Cancer
Journal Article
Blood, ISSN 0006-4971, 07/2016, Volume 128, Issue 3, pp. 325 - 330
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 2, pp. 165 - 166
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2006, Volume 354, Issue 5, pp. 496 - 507
Positron-emission tomography has become an important tool for evaluating tumors, detecting occult cancer, and staging and restaging tumors. This review... 
Neoplasm Staging - methods | Neoplasms - therapy | Neoplasm Recurrence, Local - diagnostic imaging | Positron-Emission Tomography - economics | Cost-Benefit Analysis | Humans | Fluorodeoxyglucose F18 | Radiation Dosage | False Positive Reactions | Neoplasms - diagnostic imaging | Usage | Diagnosis | Research | PET imaging | Cancer
Journal Article
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, ISSN 0889-8588, 08/2019, Volume 33, Issue 4, pp. 727 - 727
Chemotherapy nonspecifically affects all cells undergoing DNA replication and has severe side effects. Understanding of the biology of non Hodgkin lymphomas... 
Targeted agents | R-CHOP | PLUS RITUXIMAB | BRENTUXIMAB VEDOTIN | IBRUTINIB | PHASE-II | Intracellular oncogenic pathways | FOLLICULAR LYMPHOMA | OPEN-LABEL | Non-Hodgkin lymphoma | ANTI-CD20 MONOCLONAL-ANTIBODY | THERAPY | ONCOLOGY | Monoclonal antibodies | CHRONIC LYMPHOCYTIC-LEUKEMIA | HEMATOLOGY
Journal Article
Journal Article
Blood, ISSN 0006-4971, 01/2019, Volume 133, Issue 2, pp. 121 - 129
The treatment landscape for chronic lymphocytic leukemia (CLL) is rapidly evolving. Targeted agents (TAs) have demonstrated impressive single agent activity... 
MULTICENTER | VENETOCLAX | INITIAL THERAPY | PLUS RITUXIMAB | CHRONIC LYMPHOCYTIC-LEUKEMIA | OPEN-LABEL | OUTCOMES | SINGLE-ARM | INHIBITOR | HEMATOLOGY | IBRUTINIB THERAPY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.